Clinical Trial

A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations

Name: A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations — clinical trial record (NCT07647107)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tuberculosis Vaccine (Bio Farma) in Healthy Populations Aged 18-40 Years in Indonesia

Trial Details

NCT Number	NCT07647107
Lead Sponsor	PT Bio Farma Collaborators: Fakultas Kedokteran Universitas Indonesia, Dr Cipto Mangunkusumo General Hospital
Conditions	Tuberculosis, TB Infection
Enrollment	60 participants
Start Date	2026-08
Primary Completion	2027-07 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-06-15